[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@JessieChimni Jasbinder (Jessie) Chimni (My Opinions only)

Jasbinder (Jessie) Chimni (My Opinions only) posts on X about $crsp, $lctx, $sana, has been the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX -XX%
• X Month XXXXXX -XXXX%
• X Months XXXXXXX -XX%
• X Year XXXXXXX +46%

Mentions: X #

• X Week XX -XX%
• X Month XX +2.30%
• X Months XXX +43%
• X Year XXX +66%

Followers: XXXXX #

• X Week XXXXX +0.08%
• X Month XXXXX no change
• X Months XXXXX +5.40%
• X Year XXXXX +16%

CreatorRank: undefined #

Social Influence

Social category influence cryptocurrencies XXXX% finance XXXX% stocks XXXX%

Social topic influence $crsp #26, $lctx 9.52%, $sana 4.76%, has been 4.76%, $fate 4.76%, $caba 4.76%, $allo 4.76%, $acet 4.76%, $prme 4.76%, $beam XXXX%

Top accounts mentioned or mentioned by @ny1972_47 @biomedicalrx @3primeanalytica @ny197247 @wkissel @ceoculley @maddstone1 @geneinvesting @roche @genentech @iamironmanson @weekinhearing @drsamuelbhume

Top assets mentioned CRISPR Therapeutics AG (CRSP) BEAM (BEAM) Vertex Protocol (VRTX)

Top Social Posts

Top posts by engagements in the last XX hours

"This post is in the category of "pure speculation". I wonder if $CRSP have partnered with $SANA for the in-vivo CAR-T program 🤔. Steve stated at TD Cowen that they will not jeopardize SC XXX (T1D) from a capital allocation standpoint and will also not slow down SG293 (in-vivo CAR-T). He has been open to finding a partner or an investor to invest in it; he categorically stated that they will not let it die. This may be the time where the two companies see mutual benefit. Their interests are aligned and it could be a win-win for both. $CRSP definitely has the required capital and this is a"
X Link 2025-11-15T16:45Z 3614 followers, XXX engagements

"I had Claude assemble a table for the AID programs I am tracking across many companies : $FATE $CRSP $CABA $ALLO $ACET"
X Link 2025-11-15T21:22Z 3615 followers, XXX engagements

"@3primeAnalytica @GeneInvesting I wonder why they did not partner with $PRME instead 🤔. May be because of the litigation between $PRME & $BEAM regarding this indication"
X Link 2025-12-01T20:55Z 3615 followers, XXX engagements

"@IAmIronManSon $LCTX recently announced their entry into this field. If they solve the challenge I assume they will want to work with multiple companies not just one. Let's see how this plays out.Interesting times"
X Link 2025-11-16T01:26Z 3614 followers, XXX engagements

"Yet another very large TAM being targeted by $LCTX - Address hearing loss with ReSonance (ANP1)"
X Link 2025-11-20T00:13Z 3615 followers, XXX engagements

"I like the over all progress being made by $VRTX/ $CRSP Casgevy. I am unsure if they will breakeven in 2028 (as stated by Sam) or 2029 but it should be close enough. A lot will depend on their patient enrollment over the next few years. They are progressing well with all the ATCs onboarded in 2025. They initiated XXX patients by end of Q3 which was 2x of what they in 2024. Some onboarding/initiation metrics are below: ATCs: Target to onboard XX ATCs achieved Start of 2025: Over XX ATCs globally May 2025: Over XX ATCs globally August 2025: Over XX ATCs globally. Through the end of Q3 2025 25"
X Link 2025-11-12T01:10Z 3612 followers, 4377 engagements